Covered recipient · General Payments record
ZACHERY C MAHLER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,155.67
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $629.07 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $375.47 | 23 |
| Novo Nordisk AS | $90.64 | 5 |
| Acerta Pharma LLC | $54.62 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.08 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.06 | 1 |
| Amgen Inc. | $16.12 | 1 |
| Lilly USA, LLC | $14.88 | 1 |
| PFIZER INC. | $14.05 | 1 |
| GlaxoSmithKline, LLC. | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.96 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929037 | CMS |
| ABBVIE INC. | $14.20 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929041 | CMS |
| ABBVIE INC. | $16.70 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929045 | CMS |
| ABBVIE INC. | $21.43 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929049 | CMS |
| ABBVIE INC. | $7.42 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929054 | CMS |
| ABBVIE INC. | $8.88 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929058 | CMS |
| ABBVIE INC. | $23.92 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929062 | CMS |
| ABBVIE INC. | $23.54 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929066 | CMS |
| ABBVIE INC. | $12.38 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929070 | CMS |
| ABBVIE INC. | $14.40 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929073 | CMS |
| ABBVIE INC. | $32.35 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929078 | CMS |
| ABBVIE INC. | $29.79 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929081 | CMS |
| ABBVIE INC. | $9.25 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929085 | CMS |
| ABBVIE INC. | $14.15 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929090 | CMS |
| ABBVIE INC. | $24.95 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929094 | CMS |
| ABBVIE INC. | $14.05 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929098 | CMS |
| ABBVIE INC. | $4.80 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929102 | CMS |
| ABBVIE INC. | $27.73 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929106 | CMS |
| ABBVIE INC. | $7.70 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929110 | CMS |
| ABBVIE INC. | $7.99 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929114 | CMS |
| ABBVIE INC. | $8.21 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929118 | CMS |
| ABBVIE INC. | $17.11 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929122 | CMS |
| ABBVIE INC. | $12.56 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104929126 | CMS |
| Amgen Inc. | $16.12 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117617506 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.33 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105471867 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.14 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105523709 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.10 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104532388 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.05 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105869061 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.08 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118174611 | CMS |
| GlaxoSmithKline, LLC. | $13.15 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116363745 | CMS |
| Lilly USA, LLC | $14.88 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135486306 | CMS |
| Novo Nordisk Inc | $20.58 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097116206 | CMS |
| Novo Nordisk Inc | $16.89 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096966258 | CMS |
| Novo Nordisk Inc | $16.61 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096691589 | CMS |
| Novo Nordisk Inc | $13.71 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096591081 | CMS |
| Novo Nordisk Inc | $22.85 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096787256 | CMS |
| PFIZER INC. | $14.05 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131529650 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.06 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151091687 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.